INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 448m ago
HOUSE PTR47m ago
SEC 13F47m ago
ROBINHOOD CHAIN47m ago
HB
Corporate insider

Hoffman Michael B

DirectorCIK 0001290208

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells2 / 0
Max Insider Score50
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
50
HB
Hoffman Michael BDirector
ANVSAnnovis Bio, Inc.
Open-market purchase
BUY$5.00M
5.00M sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Annovis Bio, Inc.Director · Nov 6, 2026
41
HB
Hoffman Michael BDirector
ANVSAnnovis Bio, Inc.
Open-market purchase
BUY
—
5.00M sh
Nov 6, 2026
Nov 6, 2026
traded Nov 6, 2026
+0d
SEC FORM 4

Evidence